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Abstract
Background: The FTO gene harbors the strongest known susceptibility locus for obesity. While many individual studies have
suggested that physical activity (PA) may attenuate the effect of FTO on obesity risk, other studies have not been able to
confirm this interaction. To confirm or refute unambiguously whether PA attenuates the association of FTO with obesity risk,
we meta-analyzed data from 45 studies of adults (n=218,166) and nine studies of children and adolescents (n=19,268).
Methods and Findings: All studies identified to have data on the FTO rs9939609 variant (or any proxy [r
2.0.8]) and PA were
invited to participate, regardless of ethnicity or age of the participants. PA was standardized by categorizing it into a
dichotomous variable (physically inactive versus active) in each study. Overall, 25% of adults and 13% of children were
categorized as inactive. Interaction analyses were performed within each study by including the FTO6PA interaction term in
an additive model, adjusting for age and sex. Subsequently, random effects meta-analysis was used to pool the interaction
terms. In adults, the minor (A2) allele of rs9939609 increased the odds of obesity by 1.23-fold/allele (95% CI 1.20–1.26), but
PA attenuated this effect (pinteraction =0.001). More specifically, the minor allele of rs9939609 increased the odds of obesity
less in the physically active group (odds ratio =1.22/allele, 95% CI 1.19–1.25) than in the inactive group (odds ratio =1.30/
allele, 95% CI 1.24–1.36). No such interaction was found in children and adolescents.
Conclusions: The association of the FTO risk allele with the odds of obesity is attenuated by 27% in physically active adults,
highlighting the importance of PA in particular in those genetically predisposed to obesity.
Please see later in the article for the Editors’ Summary.
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Over the past three decades, there has been a global increase in
the prevalence of obesity, which has been mainly driven by changes
in lifestyle [1]. However, not everyone becomes obese in today’s
obesogenic environment. In fact, twin studies suggest that changes
in adiposity in response to environmental influences are genetically
determined [2–6]. Until recently, there were no confirmed obesity-
susceptibility loci that could be used to test whether the influence of
genetic susceptibility on obesity risk is enhanced by an unhealthy
lifestyle. However, in 2007, the intron 1 of the fat mass and obesity
associated (FTO) gene was identified as the first robust obesity-
susceptibility locus in genome-wide association studies [7,8]. Each
additional minor allele of the rs9939609 single nucleotide
polymorphism (SNP) in FTO was found to be associated with a
20%–30% increase in the risk of obesity and a 1–1.5 kg increase in
body weight [7,8]. The risk-increasing allele of FTO is common,
with 74% of individuals of European descent (HapMap CEU
population), 76% of individuals of African-American descent
(HapMap ASW population), and 28%–44% of individuals of Asian
descent (HapMap CHB, CHD, GIH, and JPT populations)
carrying at least one copy of the FTO risk allele.
After the discovery of FTO, several studies reported that its
obesity-increasing effect may be attenuated in individuals who are
physically active [9–20]. Other studies, however, were unable to
replicate this interaction [21–26], leaving it unresolved whether
physical activity (PA) can reduce FTO’s effect on obesity risk, and if
so, to what extent. Identifying interactions between genetic
variants and lifestyle is challenging as it requires much larger
sample sizes than those needed for the detection of main effects of
genes or environment [27]. Interaction studies are further
hampered by the difficulty of measuring lifestyle exposures
accurately, which reduces statistical power and necessitates large
study sample sizes to offset this effect [28].
To collect a sufficiently large sample to unambiguously confirm
or refute the interaction between FTO and PA, we meta-analyzed
data from 45 studies, totaling 218,166 adults. In addition, we
performed a similar meta-analysis among 19,268 children and
adolescents from nine studies. We included all available data, both
published and unpublished, and used standardized methods to
analyze the interaction across the studies.
Methods
Ethics Statement
All studies were conducted according to the Declaration of
Helsinki. Informed consent was obtained from all participants, and
the studies were approved by the ethics committees of the
participating institutions.
Study Design
The literature on the interaction between FTO and PA is
inconsistent with regard to the definitions used for PA, the
statistical analysis of interactions, and the presentation of
interaction results [29]. Furthermore, as statistically non-signifi-
cant interactions may often not be reported, a meta-analysis of
only published results would suffer from publication bias [29].
Therefore, a literature-based meta-analysis of the interaction
between FTO and PA was not considered appropriate. Instead, we
designed a meta-analysis based on de novo analyses of data
according to a standardized plan to achieve the greatest
consistency possible across studies, and to allow inclusion of all
available studies, irrespective of whether they had or had not been
used to examine this hypothesis in the past.
We identified all eligible studies by a PubMed literature search
in December 2009 using the search term ‘‘FTO’’ and by following
the publication history of each identified study to find those with
data on PA. Furthermore, we identified all studies with genome-
wide association data from published papers of genome-wide
association consortia by a PubMed search using the keywords
‘‘genome-wide’’ and ‘‘association,’’ and searched the literature to
determine whether these studies also had data on PA. Additional
yet-unpublished studies were identified through the network of
collaborators who joined the meta-analysis and were also included
in the meta-analysis. Analyses according to our standardized plan
were performed by each study locally, and detailed summary
statistics were subsequently submitted using our standardized data
collection form. Alternatively, datasets were sent to us to perform
the required analyses centrally (15 studies) (Tables S1 and S2).
Quality Control
The data collection form included questions that allowed testing
for internal consistency. The data were extracted automatically
and cross-checked manually. The same checks for internal
consistency were performed independent of whether the data
were analyzed locally or centrally. All ambiguities were clarified
with the respective study investigators before the final meta-
analyses. A funnel plot, along with Begg and Egger tests, was used
to test for the presence of ‘‘positive results bias’’ (i.e., to test
whether studies with positive results were more likely to participate
in the meta-analysis than those with negative or inconclusive
results) (Figure S1).
Standardization of Physical Activity
PA was measured in various ways across the participating
studies of the meta-analysis. Therefore, we standardized PA by
categorizing it into a dichotomous variable (physically inactive
versus active) in each study. In studies with categorical PA data,
adults were defined as being ‘‘inactive’’ when they had a sedentary
occupation and if they reported less than 1 h of moderate-to-
vigorous leisure-time or commuting PA per week. In studies with
continuous data on PA, adults were defined as being ‘‘inactive’’
when their level of PA was in the lowest sex-specific 20% of the
study population concerned. All other individuals were defined as
‘‘physically active.’’ For children and adolescents, a more stringent
cut-off for ‘‘inactivity’’ was chosen than for adults because of the
high average PA levels in younger children [30] and the known
weaker association between PA and childhood body mass index
(BMI) [31]. Thus, children and adolescents were defined as being
‘‘inactive’’ when their level of PA was in the lowest sex- and age-
specific 10% of the study population. The coding of the
dichotomous PA variable in each study is described in detail in
Text S1.
Genotyping
The rs9939609 SNP or a proxy (linkage disequilibrium r
2.0.8
in the corresponding ethnic group) was genotyped in each study
using either direct genotyping methods or Affymetrix and Illumina
genome-wide genotyping arrays (Text S1). The studies submitted
only data that met their quality control criteria for genotyping call
rate, concordance in duplicate samples, and Hardy-Weinberg
Equilibrium p-value (Text S1).
Measurement of BMI, Waist Circumference, and Body Fat
Percentage
BMI was calculated in each study by dividing height (in meters)
by weight (in kilograms) squared. Waist circumference was
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in the analyses. Body fat percentage was measured using dual
energy X-ray absorptiometry (seven studies), bioimpedance (11
studies), or the sum of skinfolds (seven studies) (Tables S3 and S4).
FTO6PA Interaction Analysis in Participating Studies
Each study tested for an effect of the FTO6PA interaction on
BMI, waist circumference, and body fat percentage using the
following additive genetic model:
Outcome~b0zb1SNPzb2PAzb3SNP|PAzb4agezb5male ð1Þ
The same model was used to test for an effect of the FTO6PA
interaction on the odds of obesity (BMI$30 versus BMI,25 kg/
m
2) and overweight (BMI$25 versus BMI,25 kg/m
2) in adults,
using normal-weight individuals as the reference group and testing
for an additive effect in the ‘‘log odds’’ scale. In addition, each
study tested the main effect of the FTO SNP on each outcome in
the whole study population and in the inactive and physically
active subgroups separately, using the model
Outcome~b0zb1SNPzb2agezb3male ð2Þ
Each study also tested the main effect of PA on each outcome,
using the model
Outcome~b0zb1PAzb2agezb3male ð3Þ
The interactions and associations of continuous outcome variables
were analyzed with linear regression and those of dichotomous
variables with logistic regression. In adults, BMI, waist circumfer-
ence, and body fat percentage were analyzed as non-transformed
variables, whereas in children, age- and sex-specific Z-scores of
BMI, waist circumference, and body fat percentage were used.
Where data were from case-control studies for any outcome
(Tables S1 and S2), cases and controls were analyzed separately.
In studies with multiple ethnicities, each ethnicity was analyzed
separately.
Meta-Analysis and Meta-Regression
Because of heterogeneity between the studies participating in
the meta-analysis, we pooled beta coefficients and standard errors
for the main and interaction effects from individual studies using
‘‘DerSimonian and Laird’’ random effects meta-analysis, imple-
mented by the metan command in Stata, version 11 (StataCorp).
To confirm that our results were robust, we additionally pooled
the interaction effects using the ‘‘Mantel and Haenszel’’ fixed
effects method in Stata. However, as beta coefficients of fixed
effects models and random effects models were the same (to two
decimal points’ accuracy) for all traits, we report only the results
for the random effects models. Data from adults and children were
meta-analyzed separately. In all meta-analyses, between-study
heterogeneity was tested by the Q statistic and quantified by the I
2
value. Low heterogeneity was defined as an I
2 value of 0%–25%,
moderate heterogeneity as an I
2 of 25%–75%, and high
heterogeneity as an I
2 of 75%–100% [32].
We performed a meta-regression to explore sources of
heterogeneity in our meta-analysis using the metareg command in
Stata. Meta-regression included the following study-specific
variables as covariates: study sample size, proportion of inactive
individuals, age (mean age or age group ,60 y versus $60 y), sex
(male versus female), mean BMI, study design (population- or
family-based versus case-control), self-reported ethnicity (white,
African American, Asian, Hispanic), geographic region (North
America, Europe, Asia), and measurement of PA (1: studies with a
continuous PA variable versus studies with categorical data; 2:
measurement of both occupational and leisure-time PA versus
leisure-time PA only; 3: measurement of PA with a questionnaire
versus objective measurement).
Differences in interaction effect sizes between two subgroups
were assessed with a t-test.
Results
Studies Included
Our literature search identified 47 studies with data available on
FTO and PA, of which 41 agreed to participate in our meta-
analysis (Figure 1). Furthermore, 14 additional yet-unpublished
studies that were identified through the network of collaborators
who joined the meta-analysis were also invited to participate in the
meta-analysis. We excluded one of these studies, however, because
of inadequate measurement of PA. Eventually, our final meta-
analysis comprised cross-sectional data on 218,166 adults (209,118
whites, 6,309 Asians, 1,770 African-Americans, and 969 Hispan-
ics) from 45 studies, as well as data on 19,268 white children and
adolescents from nine studies. Of the 45 studies of adults, 33 were
from Europe, ten from North America, and two from Asia. All
studies of children and adolescents were from Europe. In each
study, PA was assessed using a self-report questionnaire, an
accelerometer, or a heart rate sensor (Text S1).
Association of Physical Activity with Obesity Traits (Main
Effects)
Physically active adults had a 33% lower odds of obesity
(p=2610
213), 19% lower odds of overweight (p=7610
29),
0.79 kg/m
2 lower BMI (p=3610
215), 2.44 cm smaller waist
circumference (p=1610
220), and 1.30% lower body fat percent-
age (p=2610
215) than inactive adults (Table S1). In children, PA
did not have a statistically significant association with age- and sex-
standardized BMI (p=0.2), but physically active children had a
waist circumference 20.11 Z-score units smaller (p=0.04) and a
body fat percentage 20.21 Z-score units lower (p=0.02) than
inactive children (Table S2).
Association of FTO with Obesity Traits (Main Effects)
In adults, each additional risk allele of the FTO rs9939609
variant increased the odds of obesity and overweight by 23%
(p=7610
259) and 15% (p=6610
266), respectively (Table 1). The
risk allele also increased BMI by 0.36 kg/m
2 (,1 kg in body
weight for a person 170 cm tall) (p=2610
275), waist circumfer-
ence by 0.77 cm (p=5610
243), and body fat percentage by 0.30%
(p=2610
221) (Table 1).
In children and adolescents, each FTO risk allele increased age-
and sex-specific BMI by 0.10 Z-score units (p=1610
221), waist
circumference by 0.11 Z-score units (p=8610
216), and body fat
percentage by 0.12 Z-score units (p=2610
211) (Table S3).
FTO6PA Interaction and Obesity Traits
FTO6PA interaction and BMI. PA significantly
(betainteraction = 20.14 kg/m
2 per allele, pinteraction =0.005)
attenuated the association between the FTO variant and BMI in
our meta-analysis of 218,166 adults (Figure 2; Table 2) (i.e., a
betainteraction of 20.14 kg/m
2 represents the difference in the
BMI-increasing effect of the risk allele between physically active
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risk allele on BMI was 30% smaller in physically active individuals
(beta =0.32 kg/m
2) than in inactive individuals (beta =0.46 kg/
m
2) (Table 2).
To examine the sources of heterogeneity between studies, which
was moderate (I
2=36%) (Table 2; Figure 2), we used meta-
regression. The meta-regression indicated heterogeneity by geo-
graphic region (North America versus Europe) in the interaction
(p=0.001) (Tables S4 and S5). When we subsequently stratified our
meta-analysis by geographic region, the attenuating effect of PA on
the association between the FTO variant and BMI was more
pronounced in North American populations than in European
populations (pdifference =5 610
26) (Table 2; Figure 2). More
specifically, the BMI-increasing effect of the FTO risk allele in
physically active North Americans was 59% smaller than in inactive
North Americans (beta =0.34 versus 0.82 kg/m
2, respectively),
whereas the attenuation in the BMI-increasing effect of the risk
allele in physically active Europeans compared with inactive
Europeans was only 19% (beta =0.30 versus 0.37 kg/m
2,
respectively) (Table 2). There was no heterogeneity among North
American studies (I
2=0%), whereas moderate heterogeneity was
observed among European studies (I
2=26%) (Table 2; Figure 2). In
a further sub-group meta-regression, none of the covariates
explained a significant proportion of the remaining heterogeneity
observed in Europeans.
To test for the presence of ‘‘positive results bias’’ (i.e., whether
studies with positive results were more likely to participate in our
meta-analysis than those with negative or inconclusive results), we
drew a funnel plot of the interaction beta coefficients and standard
errors and conducted Begg and Egger tests for bias. The funnel
Figure 1. Study design of the FTO6PA interaction meta-analysis. Eligible studies were identified by a literature search, as well as through
personal contacts (indicated in the figure as ‘‘other data’’). Of all studies that were invited, 45 studies of adults (n=218,166) and nine studies of
children and adolescents (n=19,268) joined the meta-analysis. A standardized analytical plan was sent to each of the studies. Summary statistics were
subsequently meta-analyzed.
doi:10.1371/journal.pmed.1001116.g001
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non-significant (p=0.9 and p=0.8, respectively), indicating that
our results were not affected by positive results bias (Figure S1).
While we observed a strong effect of the FTO risk allele on BMI
in children and adolescents (Table S3), this effect was not modified
by their PA level (pinteraction =0.98) (Figure 3). There was no
heterogeneity between the studies (I
2=1%).
FTO6PA interaction and risk of obesity and over-
weight. Consistent with the meta-analysis of BMI, PA
attenuated the effect of the FTO risk allele on the odds of obesity
(pinteraction =0.001) and on the odds of overweight (pinteraction =
0.02) (Table 2; Figures S2 and S3). The odds of obesity for the FTO
risk allele were 27% smaller (odds ratio [OR]=1.22 versus 1.30,
respectively) and the odds of overweight were 26% smaller
(OR=1.14 versus 1.19, respectively) in physically active
individuals than in inactive individuals (Table 2). Similar to the
results for BMI, there seemed to be a more pronounced FTO6PA
interaction effect in North American populations than in
Europeans: the risk-attenuating effect of PA was more than
double in North Americans compared to Europeans (Table 2;
Figures S2 and S3).The differences in the interactioneffect between
North Americans and Europeans on the odds of obesity and
overweight were, however, not significant (pdifference =0.2 for both
obesity and overweight).
FTO6PA interaction on waist circumference and body fat
percentage. We observed a significant effect of the FTO6PA
interaction on waist circumference (betainteraction =20.33 cm,
pinteraction =0.002) and body fat percentage (betainteraction =
20.19%, pinteraction = 0.02) (Table 2; Figures S4 and S5). The
influence of the FTO risk allele on waist circumference was 33%
smaller and the influence on body fat percentage 36% smaller in
physically active individuals than in inactive individuals (Table 2).
Similar to the results for BMI, the effect of the FTO6PA interaction
on waist circumference was also more pronounced in North
American populations (betainteraction = 21.02 cm) than in
Europeans (betainteraction = 20.22 cm) (pdifference = 0.01)
(Table 2; Figure S4). We found a similar difference for body fat
percentage (betainteraction = 21.57% in North Americans versus
betainteraction = 20.18%inEuropeans)that,however,didnot reach
significance (pdifference =0.1), but few North American individuals
had data on body fat percentage (n=892) (Table 2; Figure S5).
The effect of the FTO risk allele on waist circumference and
body fat percentage in children and adolescents was not modified
by their PA level (pinteraction =0.7 and 0.4, respectively) (Figures S6
and S7). There was no heterogeneity between the studies in these
meta-analyses (I
2 = 0%).
Association of FTO with Physical Activity
There was no association between FTO and the level of PA in adults
(p=0.2) (Figure S8) or children (p=0.6) (Figure S9). No between-study
heterogeneity was found in these meta-analyses either (I
2#1%).
Discussion
By combining data from 218,166 adults from 45 studies, we
confirm that PA attenuates the influence of FTO variation on BMI
Table 1. Association of the minor (A2) allele of the rs9939609 SNP or a proxy (r
2.0.8) in the FTO gene with BMI, waist
circumference, body fat percentage, risk of obesity, and risk of overweight in a random effects meta-analysis of up to 218,166
adults.
Trait Geographic Region N Beta or OR
1 (95% CI) p-Value I
2
BMI (kg/m
2) All individuals 218,166 0.36 (0.32, 0.40) 1.8610
275 34%
Europe 164,307 0.32 (0.29, 0.34) 7.6610
2110 0%
North America 47,938 0.42 (0.32, 0.53) 1.4610
215 31%
Asia 5,921 0.59 (0.33, 0.85) 7.9610
26 39%
Waist circumference (cm) All individuals 159,848 0.77 (0.66, 0.87) 5.4610
243 28%
Europe 128,811 0.71 (0.60, 0.82) 3.4610
237 20%
North America 25,117 0.89 (0.60, 1.17) 7.5610
210 17%
Asia 5,920 1.28 (0.69, 1.86) 1.8610
25 34%
Body fat percentage (%) All individuals 61,509 0.30 (0.24, 0.36) 2.2610
221 1%
Europe 60,617 0.29 (0.23, 0.36) 2.6610
221 0%
North America 892 0.79 (0.12, 1.47) 0.021 0%
Asia NA NA NA NA
Risk of obesity (BMI $30 versus BMI ,25 kg/m
2) All individuals 131,474 1.23 (1.20, 1.26) 7.2610
259 28%
Europe 97,877 1.22 (1.19, 1.25) 1.7610
247 21%
North America 29,282 1.26 (1.19, 1.33) 3.3610
214 33%
Asia 4,315 1.48 (1.25, 1.75) 4.8610
26 0%
Risk of overweight (BMI $25 versus BMI ,25 kg/m
2) All individuals 213,564 1.15 (1.13, 1.16) 5.5610
266 10%
Europe 163,069 1.14 (1.12, 1.16) 5.6610
255 5%
North America 44,574 1.14 (1.09, 1.18) 2.4610
210 21%
Asia 5,921 1.26 (1.14, 1.40) 4.9610
26 0%
All models are adjusted for age and sex. Beta is the increase in trait per minor (A2) allele of rs9939609 or a proxy (r
2.0.8); I
2 is the heterogeneity between studies in the
association of rs9939609 with the trait.
1Values are beta for all rows except risk of obesity and risk of overweight, for which values are OR.
NA, no data available for analysis.
doi:10.1371/journal.pmed.1001116.t001
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BMI and with the odds of obesity was reduced by approximately
30% in physically active compared to inactive adults. We also
found an interaction effect on the odds of overweight and on waist
circumference and body fat percentage. No interaction between
FTO and PA was found in our meta-analysis of 19,268 children
and adolescents.
Our findings are highly relevant for public health. They
emphasize that PA is a particularly effective way of controlling
body weight in individuals with a genetic predisposition towards
obesity and thus contrast with the determinist view held by many
that genetic influences are unmodifiable. While our findings carry
an important public health message for the population in general,
they do not have an immediate impact at the individual level.
More specifically, targeting PA interventions based on FTO
genotype screening only would not accurately identify those who
would benefit most of such intervention, as the effect of the FTO
variant on body weight is relatively small (,1 kg) and the
attenuation of this effect by PA is limited. Of interest is that
current evidence does not suggest that genetic testing would lead
to an increased motivation of individuals to improve their lifestyle
[33]. On the contrary, a recent study suggests that those shown to
be genetically susceptible to obesity may even worsen their dietary
habits [33]. Convincing evidence of gene–lifestyle interactions,
however, might give people a sense of control that risk-reducing
behaviors can be effective in prevention. Thus, identifying
interactions between genes and lifestyle is important as it
demonstrates that a genetic susceptibility to obesity is modifiable
by lifestyle. Furthermore, insights from gene–lifestyle interactions
contribute to elucidating the mechanisms behind genetic regula-
tion of obesity, which may help in the development of new
treatments in the future.
Interestingly, we found a geographic difference in the
interaction of FTO with PA, which was consistent across the
studied phenotypes. In particular, the interaction was stronger in
North American populations than in populations from Europe.
Reasons for the observed geographic difference are unclear. As the
participating North American and European studies are mainly
representative of individuals of European descent, genetic
differences between them are small and unlikely to substantially
contribute to the observed difference in the interaction. However,
we speculate that the geographic difference may, at least in part,
be related to the lower average levels of PA in individuals living in
North America than in Europe [34,35]. The FTO6PA interaction
effect may materialize more in populations with a high prevalence
of very sedentary individuals [17]. Furthermore, sedentariness may
also associate with other lifestyle factors that may contribute to the
interaction, such as unhealthy diet [16,19,20], which we were not
able to adjust for in our meta-analyses and which may be more
prevalent in North American populations than in Europeans [36].
Finally, there were differences in the measurement methods used
to assess PA between North American and European studies.
More specifically, all North American studies quantified PA using
a continuous PA variable, whereas many European studies used
categorical variables. As a result, the overall number of individuals
defined as inactive was smaller in North American (20%) than in
European studies (27%). We also found that PA was associated
with a 1.34 kg/m
2 lower BMI in North American populations, but
with only a 0.72 kg/m
2 lower BMI in Europeans. As misclassi-
fication in exposure measurements usually biases the effect towards
the null, it is possible that lower accuracy of PA measurements in
European studies may have deflated the effect of PA on BMI, as
well as the interaction between FTO and PA. In our meta-
regressions, however, we did not find a significant association
between the measurement of PA and the observed FTO6PA
interaction effect (Tables S4 and S5). Nevertheless, it is likely that
our overall effect estimate for the interaction is a considerable
underestimate of the true effect because of measurement error of
PA.
In studies with continuous measures of PA, we chose to use a
definition of ‘‘inactivity’’ based on a relative (lowest 20%) cut-off of
PA levels. The use of a cut-off based on fixed percentage may have
introduced heterogeneity as the percentage may correspond to
different absolute PA values in the participating studies. However,
the use of an absolute cut-off might have led to even greater
heterogeneity, because of the wide differences in the measurement
instruments that were used to provide the continuous measures of
PA. In theory, the accuracy of a relative PA cut-off could be
improved by choosing a specific cut-off for each country on the
basis of national PA data. In practice, however, comparing PA
data between countries is difficult, as prevalence estimates for
sedentariness have been assessed by different survey instruments,
which sometimes have also changed over time, and prevalence
estimates are not always available from representative samples of
the population.
The present meta-analysis was based on cross-sectional data and
thus does not provide information on the longitudinal relationships
between variables. While germline DNA remains stable through-
out the life course, PA levels may change and may be confounded
by other lifestyle and environmental factors that correlate with PA
and body weight. So far, only three prospective follow-up studies
(nrange =502 to 15,844) on the interaction between FTO and PA
have been reported, and none showed an interaction between FTO
and baseline PA, or change in PA, on weight change during
follow-up [21–23]. Although studies investigating PA alone did not
find an interaction, the Diabetes Prevention Program in the US
showed an interaction between FTO and a 1-y lifestyle
intervention, consisting of PA, diet, and weight loss combined,
on change in subcutaneous fat area among 869 individuals [37].
The minor allele of the FTO variant was associated with an
increase in subcutaneous fat area in the control group but not in
the lifestyle intervention group [37]. Two studies have tested
whether FTO modified the effect of a standardized exercise
program on change in body weight in individuals who were
sedentary at baseline, but results were inconsistent. While the first
study showed a greater weight loss for the carriers of the major
(C2) allele of FTO rs8050136 after a 20-wk endurance training
program among 481 men and women [38], a subsequent study
with a 6-mo endurance training program among 234 women
indicated weight loss benefits for the carriers of the minor (A2)
allele of the same variant [39]. These studies may have been
insufficiently powered to detect an interaction between FTO
variation and exercise intervention. A meta-analysis of prospective
studies may be required to confirm or refute whether there is an
Figure 2. Forest plot of the effect of the interaction between the FTO rs9939609 SNP and physical activity on BMI in a random
effects meta-analysis of 218,166 adults. The studies are sorted by sample size (largest sample size lowest). Details of the studies are given in
Text S1. The interaction beta represents the difference in BMI per minor (A2) allele of rs9939609 comparing physically active individuals to inactive
individuals, adjusting for age and sex. For example, a betainteraction of 20.10 kg/m
2 for BMI represents a 0.10 kg/m
2 attenuation in the BMI-increasing
effect of the rs9939609 minor allele in physically active individuals compared to inactive individuals.
doi:10.1371/journal.pmed.1001116.g002
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sufficiently powered population sample. Finally, a large-scale
randomized controlled trial would be needed to infer causality for
the interaction between PA and FTO.
We found no interaction between the FTO variant and PA on
BMI in children and adolescents, which could be because of low
statistical power, as the sample size was 11 times smaller than in
the meta-analysis of adults. Even so, the effect size of the
interaction was null, suggesting that no attenuation of PA on the
BMI-increasing effect of FTO would be found, even if a larger
sample was meta-analyzed. The lack of interaction in children
may, at least in part, be due to the weak association between PA
and childhood BMI and the higher activity levels in children than
in adults [30]. Despite the fact that BMI is a noninvasive and easy-
to-obtain measure of adiposity, its weakness is that it does not
distinguish lean body mass from fat mass and may therefore not be
the best measure of adiposity in children. Indeed, the associations
of PA with waist circumference and body fat percentage were
significant, and the effect of the FTO6PA interaction on body fat
percentage pointed towards a slightly decreased effect of the FTO
risk allele in physically active children as compared to sedentary
children.
We designed a meta-analysis based on a de novo analysis of data
according to a standardized plan in all studies identified as having
available data. The analytical consistency across studies, which
helped minimize between-study heterogeneity, and the pooling of
all identified data, which minimized biases related to study
selection, are major strengths of our meta-analysis. A greater
consistency and statistical power could ultimately be reached only
through the establishment of large single or multicenter studies
using standardized methods and precise measurement of PA.
In summary, we have established that PA attenuates the
association of the FTO gene with adult BMI and obesity by
approximately 30%. We have also demonstrated that large-scale
international collaborations are useful for confirming interactions
between genes and lifestyle.
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Background. Two in three Americans are overweight, of
whom half are obese, and the trend towards increasing
obesity is now seen across developed and developing
countries. There has long been interest in understanding
the impact of genes and environment when it comes to
apportioning responsibility for obesity. Carrying a change in
the FTO gene is common (found in three-quarters of
Europeans and North Americans) and is associated with a
20%–30% increased risk of obesity. Some overweight or
obese individuals may feel that the dice are loaded and there
is little point in fighting the fat; it has been reported that
those made aware of their genetic susceptibility to obesity
may still choose a poor diet. A similar fatalism may occur
when overweight and obese people consider physical
activity. But disentangling the influence of physical activity
on those genetically susceptible to obesity from other
factors that might impact weight is not straightforward, as it
requires large sample sizes, could be subject to publication
bias, and may rely on less than ideal self-reporting methods.
Why Was This Study Done? The public health
ramifications of understanding the interaction between
genetic susceptibility to obesity and physical activity are
considerable. Tackling the rising prevalence of obesity will
inevitably include interventions principally aimed at
changing dietary intake and/or increasing physical activity,
but the evidence for these with regards to those genetically
susceptible has been lacking to date. The authors of this
paper set out to explore the interaction between the
commonest genetic susceptibility trait and physical activity
using a rigorous meta-analysis of a large number of studies.
What Did the Researchers Do and Find? The authors
were concerned that a meta-analysis of published studies
would be limited both by the data available to them and by
possible bias. Instead of this more widely used approach,
they took the literature search as their starting point,
identified other studies through their collaborators’
network, and then undertook a meta-analysis of all
available studies using a new and standardized analysis
plan. This entailed an extremely large number of authors
mining their data afresh to extract the relevant data points to
enable such a meta-analysis. Physical activity was identified
in the original studies in many different ways, including by
self-report or by using an external measure of activity or
heart rate. In order to perform the meta-analysis, participants
were labeled as physically active or inactive in each study.
For studies that had used a continuous scale, the authors
decided that the bottom 20% of the participants were
inactive (10% for children and adolescents). Using data from
over 218,000 adults, the authors found that carrying a copy
of the susceptibility gene increased the odds of obesity by
1.23-fold. But the size of this influence was 27% less in the
genetically susceptible adults who were physically active
(1.22-fold) compared to those who were physically inactive
(1.30-fold). In a smaller study of about 19,000 children, no
such effect of physical activity was seen.
What Do these Findings Mean? This study demonstrates
that people who carry the susceptibility gene for obesity can
benefit from physical activity. This should inform health care
professionals and the wider public that the view of
genetically determined obesity not being amenable to
exercise is incorrect and should be challenged.
Dissemination, implementation, and ensuring uptake of
effective physical activity programs remains a challenge
and deserves further consideration. That the researchers
treated ‘‘physically active’’ as a yes/no category, and how
they categorized individuals, could be criticized, but this was
done for pragmatic reasons, as a variety of means of
assessing physical activity were used across the studies. It is
unlikely that the findings would have changed if the authors
had used a different method of defining physically active.
Most of the studies included in the meta-analysis looked at
one time point only; information about the influence of
physical activity on weight changes over time in genetically
susceptible individuals is only beginning to emerge.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001116.
N This study is further discussed in a PLoS Medicine
Perspective by Lennert Veerman
N The US Centers for Disease Control and Prevention
provides obesity-related statistics, details of prevention
programs, and an overview on public health strategy in the
United States
N A more worldwide view is given by the World Health
Organization
N The UK National Health Service website gives information
on physical activity guidelines for different age groups,
while similar information can also be found from US
sources
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